Epigral's Q1 FY 2025-26 Quarter Results

Result Summary

• Epigral Ltd reported a 16.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 5.9%.
• Its expenses for the quarter were up by 22.9% QoQ and down 2.8% YoY.
• The net profit increased 107.9% QoQ and increased 87.1% YoY.
• The earnings per share (EPS) of Epigral Ltd stood at 37.3 during Q1 FY 2025-26.

Financial Statments for Q1 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Epigral Ltd is a company whose specific industry and main products or services are not detailed within the provided data. The company, like many others, is likely involved in manufacturing, services, or technology, but without explicit information, these remain assumptions. Available data do not specify recent major developments regarding acquisitions, product launches, or other strategic moves by the company. The absence of this information necessitates a focus solely on the financial performance as evidenced by the provided figures.

Revenue

In the first quarter of fiscal year 2026 (Q1FY26), Epigral Ltd reported a total income of ₹614.79 crores. This represents a substantial quarter-over-quarter (QoQ) increase of 16.8% from the previous quarter's (Q4FY25) total income of ₹526.16 crores. However, when compared to the same period in the previous year (Q1FY25), there is a year-over-year (YoY) decrease of 5.9%, where the total income stood at ₹653.60 crores. These figures reflect fluctuations in the company's revenue streams over the quarterly and yearly comparison periods.

Profitability

Epigral Ltd's profitability metrics for Q1FY26 reveal a complex picture. The company achieved a profit before tax (PBT) of ₹106.73 crores, which shows a decline of 5.4% QoQ from ₹112.85 crores in Q4FY25 and an 18.6% YoY decrease from ₹131.10 crores in Q1FY25. Interestingly, profit after tax (PAT) for Q1FY26 was ₹160.69 crores, reflecting a dramatic QoQ increase of 107.9% from ₹77.28 crores in Q4FY25 and an 87.1% YoY increase from ₹85.87 crores in Q1FY25. This indicates substantial tax adjustments, as the tax expense recorded a negative value of ₹-53.68 crores in Q1FY26. Earnings per share (EPS) followed a similar trend, doubling QoQ by 100.5% to ₹37.30 from ₹18.60 in Q4FY25 and increasing by 80.2% YoY from ₹20.70 in Q1FY25.

Operating Metrics

The total expenses for Epigral Ltd in Q1FY26 were reported at ₹508.06 crores, marking a QoQ increase of 22.9% from ₹413.31 crores in Q4FY25 but a YoY decrease of 2.8% from ₹522.50 crores in Q1FY25. The rise in expenses could be indicative of increased operational costs or strategic investments. The significant negative tax value in Q1FY26 stands out as an anomaly, impacting the net profitability positively, despite the decline in PBT. These operating metrics highlight the company's operational dynamics for the quarter under review.